Clinical Trials
3 trialsNCT05013372 2022-08-02
CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Peking University People's Hospital
Phase EARLY_PHASE1 Unknown
NCT05208853 2022-01-26
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma
Zhejiang University
Phase EARLY_PHASE1 Unknown
NCT04264078 2021-06-28
Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies
Xinqiao Hospital of Chongqing
Phase EARLY_PHASE1 Unknown